Make a meaningful comment and End this Medical Tyrrany
Part 2 with Bill and Mr X 8-13-21
Here are numerous links to take you “down the path” of the tyranny we’re currently experiencing.
Here https://www.oregon.gov/pharmacy/pages/index.aspx
To Here https://www.oregon.gov/pharmacy/Pages/Board-Members.aspx
“**There are currently multiple opportunities available for interested persons to serve on the Board as well as the Public Health & Pharmacy Formulary Advisory Committee. Visit our “Opportunities” page for more information! ”
To Here https://www.oregon.gov/pharmacy/Pages/Board-Minutes.aspx
To Here https://www.oregon.gov/pharmacy/Documents/February_2021_Bd_Mtg_Agenda.pdf
on page 62 of 100 or page 11 of legislative report
“Temporarily prohibited dispensing of chloroquine and hydroxychloroquine for COVID-19 to preserve supplies for patients with rheumatoid arthritis and lupus”
This https://www.lupus.org/news/fda-recognizes-hydroxychloroquine-and-chloroquine-shortages
took me here
https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
actual supply issues addressed https://www.outsourcing-pharma.com/Article/2020/03/23/Industry-ups-chloroquine-production
https://www.oregon.gov/pharmacy/Documents/COVID-19_Comprehensive_Communication_Doc.pdf
https://www.oregon.gov/pharmacy/Documents/COVID-19_Comprehensive_Communication_Doc.pdf
Ivermectin Prescriptions for Treating or Preventing COVID-19
“The US Food and Drug Administration has not approved ivermectin for use in treating or preventing COVID- 19 in humans and it has not been proven to be safe or effective for this indication. Pharmacists receiving prescriptions for ivermectin for the treatment or prevention COVID-19 should use their professional judgment in determining whether to fill them. If you have concerns related to the prescribing practices of a practitioner, it may be appropriate to reach out to their licensing board.
The following rules may apply: OAR 855-019-0200 General Responsibilities of a Pharmacist
The Oregon Board of Pharmacy serves to promote and protect public health, safety and welfare by ensuring high standards in the practice of pharmacy and through effective regulation of the manufacture and distribution of drugs.ORS 689.025 states that “the practice of pharmacy in the State of Oregon is declared a health care professional practice affecting the public health, safety and welfare”. Pharmacy practice is a dynamic patient-oriented health service that applies a scientific body of knowledge to improve and promote patient health by means of appropriate drug use, drug-related therapy, and communication for clinical and consultative purposes.
A pharmacist licensed to practice pharmacy by the Board has the duty to use that degree of care, skill, diligence and professional judgment that is exercised by an ordinarily careful pharmacist in the same or similar circumstances. OAR 855-019-0210 Duties of the Pharmacist Receiving a Prescription (2) A pharmacist receiving a prescription is responsible for: (a) Using professional judgment in dispensing only pursuant to a valid prescription. A pharmacist shall not dispense a prescription if the pharmacist, in their professional judgment, believes that the prescription was issued without a valid patient-practitioner relationship. In this rule, the term practitioner shall include a clinical associate of the practitioner or any other practitioner acting in the practitioner’s absence. The prescription must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of their professional practice and not result solely from a questionnaire or an internet-based relationship; On 4/2/2020, the Oregon Board of Pharmacy revised the adopted an emergency temporary rule (OAR 855-007-0085) which limits the dispensing of chloroquine and hydroxychloroquine (CQ/HCQ) as a measure to preserve supplies for treatment of malaria, inflammatory conditions, and patients with COVID-19 infection. In response to the challenges related to testing availability and delayed resulting times faced by Oregon care providers, the revised language permits dispensing of CQ/HCQ to hospitalized/institutionalized individuals with either a positive test result for COVID-19 or pursuant to a clinical diagnosis of COVID-19 infection.
- Prescription Therapy for COVID-19 Patients Informational/FAQs – updated 4/2/2020
As this situation evolves, the Board continues to reassess temporary rule OAR 855-007-0085, to continue monitoring emerging evidence, availability of testing, and by working with state leadership, the Oregon Health Authority and the Oregon Medical Board to modify or rescind the rule as appropriate .”
Additional reading here:
https://www.ama-assn.org/system/files/2020-04/board-of-pharmacy-covid-19-prescribing.pdf
go down to page 15 Oregon follow link to Sec of State OAR page ” rule not found “
https://secure.sos.state.or.us/oard/ruleSearchResults.action?ruleNumber=855-007-0085
From BIll Meyer’s blog kmed.com
Call To Action – Email the Board with your meaningful public comments, and let’s end this medical tyranny, stand for medical freedom, and allow Ivermectin and HCQ to be prescribed by our doctors OUTSIDE OF HOSPITALS and actually FILLED by our local pharmacists. Right now the rules are setup to REQUIRE Oregon Pharmacists to REPORT Doctors who prescribe HCQ and Ivermectin and they can actually LOSE THEIR LICENSE. Under the current administrative rule (NOT a LAW) HCQ can be given to someone in Oregon ONLY inside the hospital, and by then it’s often too late to be effective. Email address is pharmacy.board@bop.oregon.gov
Oh, an interesting bit of reading on a Ivermectin Study from the American Journal of Therapeutics:
Conclusions:
Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.
Recent Comments